Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Robert T. Dorr

Verified by OpenAlex author ID and NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109911423; NIH RePORTER profile ID 2104590. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
1
Labs led
1
Collaborators
5
Papers, trials and grants by year

2011: 1 grant · 2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper

Papers 2

  1. Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors. Co-author DOI 10.4161/15384047.2014.986967↗
  2. Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cells. Last author DOI 10.1158/1541-7786.mcr-11-0359↗

Grants 1

  1. Therapeutic Targeting of Hypoxic and Oxidative Stress P01CA017094↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tomislav Dragovich · 1 shared grant, 2011 · strength 0.11
  2. Betty K. Samulitis · 2 shared papers, 2012–2015 · strength 0.09
  3. Terry H. Landowski · 2 shared papers, 2012–2015 · strength 0.09
  4. Elena V. Sheveleva · 1 shared paper, 2012 · strength 0.04
  5. Garth Powis · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.